Navigation Links
Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM)
Date:5/18/2008

begin to improve in as few as 12 hours. Maximum relief may take several days. Results may vary. If side effects, they are generally mild and may include headache, nosebleed, or sore throat.

About GlaxoSmithKline

GlaxoSmithKline is one of the world's leading research-based pharmaceutical and healthcare companies. GlaxoSmithKline is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit http://www.gsk.com.


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
2. Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
3. Pharmacopeias First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients
4. New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
5. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
6. Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer
7. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
8. New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)
9. AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients
10. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
11. Prism Glasses Expand the View for Patients with Hemianopia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...v. 9 /PRNewswire-Asia-FirstCall/ -- American Orien...any" or "AOBO"), a pharmaceutical,company dedicate...ufacture and,commercialization of a broad range of...s, today announced that it plans to release third ... 16, 2009, after the market closes. , The...
(Date:11/9/2009)...N.J., Nov. 9 Par Pharmac...ced that it has extended the expiration date and i...unced "Modified Dutch Auction" tender offer, in wh...65,000,000 aggregate principal amount, or up to ap...r Subordinated Convertible Notes due 2010. ,, T...
(Date:11/9/2009)...9, 2009 Arena Pharmaceut...ial results for the third quarter ended September ...locable to common stockholders in the third quarte...mpared to a net loss allocable to common stockhold... or $0.76 per share, and a net loss allocable to c...
Breaking Medicine Technology:Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9Customers Design Reid Supply 26apos 3Bs New Web Site 50846 1Customers Design Reid Supply 26apos 3Bs New Web Site 50846 2Customers Design Reid Supply 26apos 3Bs New Web Site 50846 3Customers Design Reid Supply 26apos 3Bs New Web Site 50846 4Customers Design Reid Supply 26apos 3Bs New Web Site 50846 5MRI accurately depicts deep endometriosis 50842 1MRI accurately depicts deep endometriosis 50842 2SoundBite 28TM 29 Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology 26 Neurotology Journal 50838 1SoundBite 28TM 29 Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology 26 Neurotology Journal 50838 2SoundBite 28TM 29 Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology 26 Neurotology Journal 50838 3
...t and Phase 1b Combination Clinical Trials ...y, SOUTH SAN FRANCISCO, Calif., June 16 Sunesis,...ata Saturday from two,clinical trials of the compa...595), including updated results of a Phase 1 trial...sed or refractory patients with acute,myeloid leuk...
...Pharmaceuticals,Inc. (Amex: ANX ) today provided ... Phase 2b clinical trial of CoFactor for the treat...verall survival results in this,study have been re...fluorouracil) arm demonstrating a 14 day improveme...5-FU arm., "In the Phase 2b study, CoFactor was d...
Other Medicine Technology:Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 2Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 3Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 4Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 5Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 6ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results 2ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results 3
(Date:11/9/2009)... may be left atrial enlargement, study finds , ...y is a major risk factor for left atrial enlargeme...n, stroke and death, a new study shows. , Atria...ia (an irregular heart rhythm or heartbeat). ,... aged 25 to 74, in Germany who were followed for 1...
(Date:11/9/2009)...ikely due to fact that both eye conditions are age...v. 9 (HealthDay News) -- Cataract surgery doesn,t ...ular degeneration (AMD), according to a new study ... of vision loss worsens the other. , "Because b...viduals with cataract also have AMD," wrote Li Min...
(Date:11/9/2009)...y of care increases with longer doctor visits, res...ay News) -- Family doctors are now taking more tim... often and improving the quality of visits, a new ...h their primary care physicians during office visi...and overall they seemed to receive better care," s...
(Date:11/9/2009)... Course, to be Offered in April...oolkit , Cambridge, MA (V...hysicians for Human Rights (PHR) first inspected a...stan , he realized he would need a team of experts...ting the site properly was a key first step in sec...
(Date:11/9/2009)...LEBANON, Tenn., Nov. 9 Health Conn...ounced it will host their inaugural Hospital O.R. ...10 at the Marriott Renaissance Hotel in Nashville,...more than 100 hospital operating room directors an...health systems in the country. Some of the confirm...
Breaking Medicine News(10 mins):Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2Health News:Doctors Spending More Time Now With Patients 2Health News:Doctors Spending More Time Now With Patients 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2
...f money, and ,lack of time, as, the top three fac...hing changes that benefit their ...rom a survey,released today reveal that the vast m...e actually successful. The,survey, commissioned by...
...a precarious time, as about 15 percent of women wh...ry. This risk increases when pregnant women underg...ry (HSS) in New York instituted a same-day pregnan...regnancies to the benefit of the patient, the phys...
...s of Biovail,Corporation (NYSE: BVF )(TSX: BVF) t...EO of Biovail Corporation:, , June 16, 2008, Wil...ration 7150 Mississauga Road Mississauga, Ontari...ovail shareholders have an important decision to m...
...the American Medical Association (AMA), Patrick W....MA,s Council of Ethical and Judicial Affairs,(CEJA...cal and Judicial Affairs (CEJA) develops ethics,po...address timely ethical issues that confront physic...
...of hot flashes that they experience by more than 4...r verbal memory, according to a study by researche...e study is published online and will appear in the... memory performance. , Memory complaints are comm...
... bound for baldness , , MONDAY, June 16 (H...e losing? , Start counting -- the hairs on your c...chives of Dermatology , scientists demonstrate tha...ch can be carried out in the convenience of your o...
Other Medicine News:Health News:LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful 2Health News:LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful 3Health News:LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful 4Health News:Same-day pregnancy test provides valuable guidance to pre-surgery patients 2Health News:Letter Challenges Biovail CEO to a Debate 2Health News:Letter Challenges Biovail CEO to a Debate 3Health News:Hot flashes underreported and linked to forgetfulness 2Health News:Countdown to Hair Loss 2Health News:Countdown to Hair Loss 3
VACUETTE EDTA tubes - Ridged (safety screw cap)
...taminase (tTg) is a ubiquitous enzyme that catalyz...aminase is also the specific protein that is ident...e (EMA) tests (Bio-Rad catalog number 29003 and 29...ighly sensitive and specific for celiac disease di...
...ff gets the training it needs with the NetLearning...nd Human Capital Management System in one. Whether... and HIPAA, understanding compliance reporting for...eloping skills through continuing education course...
Anal Canal EMG Starter Kit
Medicine Products: